铜绿假单胞菌临床分布及耐药性分析  

Clinical distribution and drug resistance analysis of pseudomonas aeruginosa

作　　者：吕江峰[1] 徐凤玲[1] 刘丽娟[1] 

机构地区：[1]莱芜市人民医院检验科,山东莱芜271100

出　　处：《医学检验与临床》2015年第4期79-81,共3页Medical Laboratory Science and Clinics

摘　　要：目的：了解铜绿假单胞菌（PAE）临床分布特点及耐药性，为临床医师抗感染治疗提供实验室依据。方法：回顾分析2014年1月至2014年12月医院送检感染标本分离的296株铜绿假单胞菌，对其病区、标本来源及耐药性进行分析。结果：铜绿假单胞菌检出主要来自痰标本，占72.6%。ICU成为该菌的感染的重点科室，占44.3%，该病区感染的PAE表现出了高耐药性。碳青霉烯类药物仍是除ICU外其它科室治疗PAE感染的最佳药物。结论：铜绿假单胞菌是医院感染中重要的条件致病菌，且表现了多耐药性；临床要重视并合理使用抗菌药物，减少多耐药菌株的产生。Objective：To study the distribution and drug resistance of Pseudomonas aeruginosa（PAE） for clinical use of antibiotics. Methods：The two hundred and ninety six PAE streins from Jan 2014 to Dec were retropectively analyzed about the infectious distribution and drug resistance.Results：Among the samples, PAE mainly isolated from the sputum of the patients（72.6%）. It also were the major infection site in the intensive care unit（ ICU）, and showed higher drug resistance （44.3%）. Carbapenems were the best drugs for PAE infection except ICU. Conclusions：PAE is the major conditional pathogenic bacterium causing nosocomial infection and presents the multidrug resistance. It should pay attention to the rational application of antibiotics to reduce the multi-drug resistantstrains.

关 键 词：铜绿假单胞菌 分布率 耐药性 

分 类 号：R378.991[医药卫生—病原生物学]